-
1
-
-
0842282796
-
Analysis of chromatin attachment and partitioning functions of bovine papillomavirus type 1 E2 protein
-
A. Abroi, I. Ilves, S. Kivi, and M. Ustav Analysis of chromatin attachment and partitioning functions of bovine papillomavirus type 1 E2 protein J. Virol. 78 2004 2100 2113
-
(2004)
J. Virol.
, vol.78
, pp. 2100-2113
-
-
Abroi, A.1
Ilves, I.2
Kivi, S.3
Ustav, M.4
-
2
-
-
0034615972
-
HIV-1 nomenclature proposal
-
D.L. Robertson, J.P. Anderson, J.A. Bradac, J.K. Carr, B. Foley, R.K. Funkhouser, F. Gao, B.H. Hahn, M.L. Kalish, C. Kuiken, G.H. Learn, T. Leitner, F. McCutchan, S. Osmanov, M. Peeters, D. Pieniazek, M. Salminen, P.M. Sharp, S. Wolinsky, and B. Korber HIV-1 nomenclature proposal Science 288 2000 55 56
-
(2000)
Science
, vol.288
, pp. 55-56
-
-
Robertson, D.L.1
Anderson, J.P.2
Bradac, J.A.3
Carr, J.K.4
Foley, B.5
Funkhouser, R.K.6
Gao, F.7
Hahn, B.H.8
Kalish, M.L.9
Kuiken, C.10
Learn, G.H.11
Leitner, T.12
McCutchan, F.13
Osmanov, S.14
Peeters, M.15
Pieniazek, D.16
Salminen, M.17
Sharp, P.M.18
Wolinsky, S.19
Korber, B.20
more..
-
3
-
-
0034978733
-
Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development
-
J.P. Moore, P.W. Parren, and D.R. Burton Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development J. Virol. 75 2001 5572 5721
-
(2001)
J. Virol.
, vol.75
, pp. 5572-5721
-
-
Moore, J.P.1
Parren, P.W.2
Burton, D.R.3
-
4
-
-
14844359760
-
Do clades matter for HIV vaccines?
-
P. Kahn Do clades matter for HIV vaccines? IAVI Report. 7 2003 1 16
-
(2003)
IAVI Report.
, vol.7
, pp. 1-16
-
-
Kahn, P.1
-
5
-
-
0036340475
-
Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1)
-
K. Yusim, C. Kesmir, B. Gaschen, M.M. Addo, M. Altfeld, S. Brunak, A. Chigaev, V. Detours, and B.T. Korber Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) J. Virol. 76 2002 8757 8768
-
(2002)
J. Virol.
, vol.76
, pp. 8757-8768
-
-
Yusim, K.1
Kesmir, C.2
Gaschen, B.3
Addo, M.M.4
Altfeld, M.5
Brunak, S.6
Chigaev, A.7
Detours, V.8
Korber, B.T.9
-
6
-
-
0037189323
-
Diversity considerations in HIV-1 vaccine selection
-
B. Gaschen, J. Taylor, K. Yusim, B. Foley, F. Gao, D. Lang, V. Novitsky, B. Haynes, B.H. Hahn, T. Bhattacharya, and B. Korber Diversity considerations in HIV-1 vaccine selection Science 296 2002 2354 2360
-
(2002)
Science
, vol.296
, pp. 2354-2360
-
-
Gaschen, B.1
Taylor, J.2
Yusim, K.3
Foley, B.4
Gao, F.5
Lang, D.6
Novitsky, V.7
Haynes, B.8
Hahn, B.H.9
Bhattacharya, T.10
Korber, B.11
-
7
-
-
10444271714
-
Biodistribution and general safety of a naked DNA plasmid, GTU-MultiHIV, in a rat, using a quantitative PCR method
-
M. Tuomela, M. Malm, M. Wallen, I. Stanescu, K. Krohn, and P. Peterson Biodistribution and general safety of a naked DNA plasmid, GTU-MultiHIV, in a rat, using a quantitative PCR method Vaccine 23 2005 890 896
-
(2005)
Vaccine
, vol.23
, pp. 890-896
-
-
Tuomela, M.1
Malm, M.2
Wallen, M.3
Stanescu, I.4
Krohn, K.5
Peterson, P.6
-
8
-
-
0034575447
-
Plasmid DNA for pharmaceutical applications
-
M. Schleef, T. Schmidt, and E. Flaschen Plasmid DNA for pharmaceutical applications Dev. Biol. 104 2000 25 31
-
(2000)
Dev. Biol.
, vol.104
, pp. 25-31
-
-
Schleef, M.1
Schmidt, T.2
Flaschen, E.3
-
9
-
-
0037137536
-
Viral evolution and challenges in the development of HIV vaccines
-
D.H. Barouch, and N.L. Letwin Viral evolution and challenges in the development of HIV vaccines Vaccine Suppl. 4 2002 66 68
-
(2002)
Vaccine Suppl.
, vol.4
, pp. 66-68
-
-
Barouch, D.H.1
Letwin, N.L.2
-
10
-
-
0030754098
-
Anti-HIV env immunities elicited by nucleic acid vaccines
-
J.W. Shiver, M.E. Davies, Y. Yasutomi, H.C. Perry, D.C. Freed, N.L. Letvin, and M.A. Liu Anti-HIV env immunities elicited by nucleic acid vaccines Vaccine 15 1997 884 887
-
(1997)
Vaccine
, vol.15
, pp. 884-887
-
-
Shiver, J.W.1
Davies, M.E.2
Yasutomi, Y.3
Perry, H.C.4
Freed, D.C.5
Letvin, N.L.6
Liu, M.A.7
-
11
-
-
17144465337
-
Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239
-
H. Horton, T.U. Vogel, D.K. Carter, K. Vielhuber, D.H. Fuller, T. Shipley, J.T. Fuller, K.J. Kunstman, G. Sutter, D.C. Montefiori, V. Erfle, R.C. Desrosiers, N. Wilson, L.J. Picker, S.M. Wolinsky, C. Wang, D.B. Allison, and D.I. Watkins Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239 J. Virol. 76 2002 7187 7202
-
(2002)
J. Virol.
, vol.76
, pp. 7187-7202
-
-
Horton, H.1
Vogel, T.U.2
Carter, D.K.3
Vielhuber, K.4
Fuller, D.H.5
Shipley, T.6
Fuller, J.T.7
Kunstman, K.J.8
Sutter, G.9
Montefiori, D.C.10
Erfle, V.11
Desrosiers, R.C.12
Wilson, N.13
Picker, L.J.14
Wolinsky, S.M.15
Wang, C.16
Allison, D.B.17
Watkins, D.I.18
-
12
-
-
4344573018
-
Neutralizing antibody responses to HIV: Role in protective immunity and challenges for vaccine design Expert Rev
-
I.K. Srivastava, J.B. Ulmer, and S.W. Barnett Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design Expert Rev Vaccines 3 2004 33 52
-
(2004)
Vaccines
, vol.3
, pp. 33-52
-
-
Srivastava, I.K.1
Ulmer, J.B.2
Barnett, S.W.3
-
13
-
-
0034578390
-
Priming of CTL responses by DNA vaccines: Direct transfection of antigen presenting cells versus cross-priming
-
J.B. Ulmer, and G.R. Otten Priming of CTL responses by DNA vaccines: direct transfection of antigen presenting cells versus cross-priming Dev. Biol. 104 2000 9 14
-
(2000)
Dev. Biol.
, vol.104
, pp. 9-14
-
-
Ulmer, J.B.1
Otten, G.R.2
-
14
-
-
2942519878
-
DNA vaccines against human immunodeficiency virus type 1
-
M.J. Estcourt, A.J. McMichael, and T. Hanke DNA vaccines against human immunodeficiency virus type 1 Immunol. Rev. 199 2004 144 155
-
(2004)
Immunol. Rev.
, vol.199
, pp. 144-155
-
-
Estcourt, M.J.1
McMichael, A.J.2
Hanke, T.3
-
15
-
-
0031717892
-
More ado about HIV's origins
-
S. Wain-Hobson More ado about HIV's origins Nat. Med. 4 1998 1001 1002
-
(1998)
Nat. Med.
, vol.4
, pp. 1001-1002
-
-
Wain-Hobson, S.1
-
16
-
-
0022449103
-
Interleukin 2 production in HTLV-II/LAV infection: Evidence of defective antigen-induced, but normal mitogen-induced IL-2 production
-
J. Antonen, and K. Krohn Interleukin 2 production in HTLV-II/LAV infection: evidence of defective antigen-induced, but normal mitogen-induced IL-2 production Clin. Exp. Immunol. 65 1986 489 496
-
(1986)
Clin. Exp. Immunol.
, vol.65
, pp. 489-496
-
-
Antonen, J.1
Krohn, K.2
|